Mazyar Yazdani

Dr. Mazyar Yazdani

Medical Biochemistry, Oslo University Hospital, Oslo, Norway
orcid
Senior Scientist at Oslo University Hospital, Norway

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

6 July 2024 in Biological Trace Element Research
Verified
Journal Article
Open access
PDF file
TRTara Rolić
Tara Rolić
Mazyar YazdaniMazyar Yazdani
Mazyar Yazdani
SMSanja Mandić
Sanja Mandić
SDSonia Distante
Sonia Distante
Iron (Fe) is fundamental to life on earth. In the human body, it is both essential and harmful if above threshold. A similar balance applies to other elements: calcium (Ca), magnesium (Mg), and trace elements including copper (Cu), zinc (Zn), lead (Pb), cadmium (Cd), mercury (Hg), and nickel (Ni). These elements share some proteins involved in the absorption and transport of Fe. Cu and Cd can inhibit Fe absorption, while excess of Fe may antagonize Cu metabolism and reduce ceruloplasmin (Cp). Excessive Fe can hinder Zn absorption and transferrin (Trf) can bind to both Zn and Ni. Ca is able to inhibit the divalent metal transporter 1 (DMT1) in a dose-dependent manner to reduce Fe absorption and low Mg concentrations can exacerbate Fe deficiency. Pb competitively inhibits Fe distribution and elevated Cd absorption reduces Fe uptake. Exposure to Hg is associated with higher ferritin concentrations and Ni alters intracellular Fe metabolism. Fe removal by phlebotomy in hemochromatosis patients has shown to increase the levels of Cd and Pb and alter the concentrations of trace elements in some types of anemia. Yet, the effects of chronic exposure of most trace elements remain poorly understood.

Verified
Journal Article
Open access
PDF file
Mazyar YazdaniMazyar Yazdani
Mazyar Yazdani
KEKatja Benedikte Presto Elgstoen
Katja Benedikte Presto Elgstoen
HRHelge Rootwelt
Helge Rootwelt
ASAboulghassem Shahdadfar
Aboulghassem Shahdadfar
ØUØygunn Aass Utheim
Øygunn Aass Utheim
TUTor Paaaske Utheim
Tor Paaaske Utheim
Dry eye disease (DED) is a multifactorial syndrome that can be caused by alteration in the quality or quantity of the precorneal tear film. It is considered one of the most common ocular conditions leading patients to seek eye care. The current method for diagnostic evaluations and follow-up examinations of DED is a combination of clinical signs and symptoms determined by clinical tests and questionnaires, respectively. The application of powerful omics technologies has opened new avenues toward analysis of subjects in health and disease. Metabolomics is a new emerging and complementary research discipline to all modern omics in the comprehensive analysis of biological systems. The identification of distinct metabolites and integrated metabolic profiles in patients can potentially inform clinicians at an early stage or during monitoring of disease progression, enhancing diagnosis, prognosis, and the choice of therapy. In ophthalmology, metabolomics has gained considerable attention over the past decade but very limited such studies have been reported on DED. This paper aims to review the application of tear metabolomics in DED.

1 October 2020 in The Ocular Surface
Verified
Journal Article
Open access
BTBehzod Tashbayev
Behzod Tashbayev
Mazyar YazdaniMazyar Yazdani
Mazyar Yazdani
RAReiko Arita
Reiko Arita
FFFredrik Andreas Fineide
Fredrik Andreas Fineide
TUTor Paaske Utheim
Tor Paaske Utheim
To review the published literature related to application of intense pulsed light (IPL) for treating meibomian gland dysfunction (MGD). The literature search included the PubMed database and used the keywords "Intense Pulsed Light and Meibomian Gland Dysfunction". IPL is a new instrumental treatment modality for MGD. This treatment modality was originally developed for use in dermatology and was later adopted in ophthalmology for treating MGD. IPL therapy for MGD can improve tear film stability, meibomian gland functionality, as well as subjective feeling of ocular dryness. However, in the reviewed literature, there was great variability in patient selection, evaluation criteria, and treatment protocols and durations. Numerous studies report that IPL is effective for treating MGD and a safe procedure. There is great potential for further improvements to the procedure, as large comparative studies employing different treatment modalities are lacking.

14 March 2019 in Cells
Verified
Journal Article
Open access
PDF file
Mazyar YazdaniMazyar Yazdani
Mazyar Yazdani
ASAboulghassem Shahdadfar
Aboulghassem Shahdadfar
CJCatherine Jackson
Catherine Jackson
TUTor Paaaske Utheim
Tor Paaaske Utheim
Hyaluronan (HA), also termed hyaluronic acid or hyaluronate, is a major component of the extracellular matrix. This non-sulfated glycosaminoglycan plays a key role in cell proliferation, growth, survival, polarization, and differentiation. The diverse biological roles of HA are linked to the combination of HA’s physicochemical properties and HA-binding proteins. These unique characteristics have encouraged the application of HA-based hydrogel scaffolds for stem cell-based therapy, a successful method in the treatment of limbal stem cell deficiency (LSCD). This condition occurs following direct damage to limbal stem cells and/or changes in the limbal stem cell niche microenvironment due to intrinsic and extrinsic insults. This paper reviews the physical properties, synthesis, and degradation of HA. In addition, the interaction of HA with other extracellular matrix (ECM) components and receptor proteins are discussed. Finally, studies employing HA-based hydrogel scaffolds in the treatment of LSCD are reviewed.

26 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BTBezhod Tashbayev
Bezhod Tashbayev
TUTor Paaske Utheim
Tor Paaske Utheim
ØUØygunn Aass Utheim
Øygunn Aass Utheim
SRSten Ræder
Sten Ræder
JJJanicke Jensen
Janicke Jensen
XCXiangjun Chen
Xiangjun Chen
The prevalence of dry eye disease is high worldwide and poses a great burden on patients’ daily lives. Accurate diagnosis of the disease is important, and it requires application of various methods. Hyperosmolarity is believed to be the disease marker and thus measuring it provides useful information. In this study we investigated utility of tear osmolarity measured with TearLab osmometer, along with other diagnostic tests (Ocular Surface Disease Index questionnaire, Tear film break-up time, Ocular Protection Index, Ocular Surface Staining, Schirmer I test, Meibomian gland functionality in 757 patients (1514 eyes) with dry eye disease and 29 healthy controls (58 eyes). Statistical differences between the patient group and the control group were observed for all the tests apart from tear osmolarity, regardless of cut-off value (>308 mOsm/L, >316 mOsm/L, and inter-eye difference >8 mOsm/L). Moreover, in the receiver operating characteristics curve analyses tear osmolarity measurement could not discriminate dry eye disease pathological scores. Therefore, our study suggests that tear osmolarity measured with TearLab osmometer cannot be used as a key indicator of DED.